Efgartigimod (Vyvgart) (AChR-positive gMG) Company: Argenx Clinical trial(s): ADAPT (Stage 3 complete) More information NICE status: In negotiations with NICE after 3rd appraisal committee meeting MHRA status: Approved Learn more about Efgartigimod. Manage Cookie Preferences